To Joe Bruman et als:
Re: MSG
The Parkinson Study Group, made up of researchers from
the U.S.A. and Canada, is designing a clinical trial to study
the safety of using glutamate antagonists to treat PD.
Glutamate is an amino acid which causes nerve cells to
become active (excitatory neurotransmitter). Researchers
have found that when dopamine decreases there is a
corresponding increase in activity of the subthalamic nucleus
which sends glutamate messages to control movement,
which leads to tremors. Researchers think that the increase
in glutamate messages could have a toxic effect on nerve
cells, hence the search for glutamate antagonists to block
the messages.
Dr. Carlos Singer, M.D., a consultant to the NPF at the
Univ. of Miami, is part of the Parkinson Study Group.
Stephan 53/7
